United States

MYOS RENS Technology Inc (MYOS.OQ)

MYOS.OQ on NASDAQ Stock Exchange Capital Market

22 Feb 2018
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


MYOS RENS Technology Inc. (MYOS), formerly MYOS Corporation, is an early-stage bionutrition and biotherapeutics company. The Company is focused on the discovery, development and commercialization of products that improve muscle health and function essential for the management of sarcopenia, cachexia and degenerative muscle... (more)
No analyst recommendations are available for .


Beta: 0.46
Market Cap(Mil.): $8.76
Shares Outstanding(Mil.): 6.34
Dividend: --
Yield (%): --


  Industry Sector
P/E (TTM): -- 21.60 16.31
EPS (TTM): -- -- --
ROI: -- 12.12 35.74
ROE: -- 15.28 17.71

BRIEF-Myos Rens Technology CEO Issues Shareholder Letter

* MYOS RENS TECHNOLOGY CEO ISSUES SHAREHOLDER LETTER Source text for Eikon: Further company coverage:

Jan 11 2018

BRIEF-MYOS RENS Technology reports qtrly loss per share $‍0.13​

* MYOS RENS Technology Inc reports third quarter 2017 financial results

Nov 14 2017

BRIEF-Myos Rens Technology files for mixed shelf of up to $75 mln

* Files for mixed shelf of up to $75 million - sec filing Source text: (http://bit.ly/2z7GifH) Further company coverage:

Oct 25 2017

BRIEF-Myos Rens Technology Inc appoints Joseph Mannello as permanent CEO

* Myos Rens Technology Inc appoints Joseph Mannello as permanent chief executive officer

Sep 20 2017

BRIEF-Myos Rens Technology elects Joseph Mannello CEO​

* Myos Rens Technology Inc says ‍on August 24 board elected Joseph Mannello as chief executive officer of company, effective immediately - SEC filing​

Aug 28 2017

Earnings vs. Estimates

No consensus analysis data available.